Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$191,988,358
+$82,495,503 QoQ
Shares Held
2,253,649
+35.7% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#12
of 480 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$2,096,820
PutShares
33,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. CYTK ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $191,988,358 | 2,253,649 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $109,492,855 | 1,661,248 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $153,932,766 | 2,422,612 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $2,096,820 | 33,000 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $152,949,832 | 2,782,930 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $92,459,169 | 2,798,401 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $98,696,070 | 2,455,737 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $103,333,755 | 2,196,721 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $123,438,321 | 2,337,847 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $132,993,749 | 2,454,665 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $112,566,933 | 1,605,576 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $118,309,838 | 1,417,054 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $78,199,949 | 2,654,445 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $86,587,995 | 2,654,445 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $91,905,441 | 2,611,692 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $124,849,282 | 2,724,777 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $129,441,345 | 2,671,648 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $118,916,999 | 3,026,648 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $117,103,653 | 3,181,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $167,368,347 | 3,671,969 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $107,751,882 | 3,014,882 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $48,071,889 | 2,429,100 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,148,021 | 2,671,884 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $67,989,749 | 3,271,884 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||